4//SEC Filing
Ozawa Clare 4
Accession 0000899243-22-001359
CIK 0001720725other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 4:18 PM ET
Size
16.6 KB
Accession
0000899243-22-001359
Insider Transaction Report
Form 4
Clare Ozawa
Director
Transactions
- Other
Common Stock
2022-01-05−200,213→ 414,607 total(indirect: See Footnotes) - Other
Common Stock
2022-01-05+51,556→ 51,556 total(indirect: See Footnotes) - Other
Common Stock
2022-01-05+120→ 11,064 total - Other
Common Stock
2022-01-05−51,556→ 0 total(indirect: See Footnotes) - Other
Common Stock
2022-01-05−1,261→ 2,465 total(indirect: See Footnotes)
Holdings
- 2,236,888(indirect: See Footnotes)
Common Stock
- 1,003,658(indirect: See Footnotes)
Common Stock
Footnotes (10)
- [F1]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital IV, L.P. ("Versant IV") to its partners pursuant to a Rule 10b5-1 trading plan.
- [F10]Shares held by Versant Vantage I, L.P. ("Versant Vantage"). Versant Vantage I GP-GP, LLC ("Versant Vantage I GP-GP") is the sole general partner of Versant Vantage I GP, L.P. ("Versant Vantage I GP") and Versant Vantage I GP is the sole general Partner of Versant Vantage. The Reporting Person, a member of the Issuer's board of directors, is a managing member of Versant Vantage I GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant Vantage. Each of Versant Vantage I GP-GP, Versant Vantage I GP, and the Reporting Person disclaims beneficial ownership of the shares held by Versant Vantage, except to the extent of their respective pecuniary interests therein.
- [F2]Shares held by Versant IV. Versant Ventures IV, LLC ("Versant Ventures IV") is the sole general partner of Versant IV. Versant Ventures IV disclaims beneficial ownership of the shares held by Versant IV, except to the extent of its pecuniary interest therein.
- [F3]Represents a change in the form of ownership of Versant Ventures IV by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant IV.
- [F4]Shares held by Versant Ventures IV.
- [F5]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Ventures IV, to its members.
- [F6]Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by Versant Ventures IV.
- [F7]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Side Fund IV, L.P. ("Versant Side Fund IV") to its partners pursuant to a Rule 10b5-1 trading plan.
- [F8]Shares held by Versant Side Fund IV. Versant Ventures IV is the sole general partner of Versant Side Fund IV. Versant Ventures IV disclaims beneficial ownership of the shares held by Versant Side Fund IV, except to the extent of its pecuniary interest therein.
- [F9]Shares held by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the sole general partner of Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") and Versant Ventures VI GP is the sole general partner of Versant VI. The Reporting Person, a member of the Issuer's board of directors, is a managing member of Versant Ventures VI GP-GP and may be deemed to share voting and dispositive power over the shares held by Versant VI. Each of Versant Ventures VI GP-GP, Versant Ventures VI GP and the Reporting Person disclaims beneficial ownership of the shares held by Versant VI, except to the extent of their respective pecuniary interests therein.
Documents
Issuer
Oyster Point Pharma, Inc.
CIK 0001720725
Entity typeother
Related Parties
1- filerCIK 0001746742
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 4:18 PM ET
- Size
- 16.6 KB